Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thyroid disease in pregnancy".)

International

●Endocrine Society (ES): Clinical practice guideline for the management of thyroid dysfunction during pregnancy and postpartum (2012)

United States

●American Association of Endocrine Surgeons (AAES): Guidelines for the definitive surgical management of thyroid disease in adults (2020)

●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on thyroid disease in pregnancy (2020)

●Choosing Wisely: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (2013, updated 2018)

●American Thyroid Association (ATA): Guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum (2017)

●ATA: Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis (2016)

●ATA: Practice recommendations for radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I (2011)

Europe

●European Group on Graves' Orbitopathy (EUGOGO): Clinical practice guidelines for the medical management of Graves' orbitopathy (2021)

●European Thyroid Association (ETA): Guidelines on the management of thyroid dysfunction following immune reconstitution therapy (2019)

●ETA: Guideline for the management of Graves' hyperthyroidism (2018)

●ETA: Guidelines for the management of amiodarone-associated thyroid dysfunction (2018)

●ETA: Guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism (2015)

●ETA: Guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations (2012)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on thyroid disease – Assessment and management (2019)

●NICE: Interventional procedures guidance – Minimally invasive video-assisted thyroidectomy (2014)